Up Next
0
Onyx Rejects Amgen's $10 Billion Bid
Onyx Pharmaceuticals has rejected a $10 billion takeover bid from Amgen, reports CNBC's Bertha Coombs.
Share
Onyx Rejects Amgen's $10 Billion Bid
Onyx Pharmaceuticals has rejected a $10 billion takeover bid from Amgen, reports CNBC's Bertha Coombs.
Date: 7/1/13
Views: 94
Video by:  CNBC
 
Follow us:
Loading... 1 of 167
Today's Most Watched Videos
Related Videos
Loading... 1 of 56